| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |